Publicacións en colaboración con investigadores/as de Hospital de Fuenlabrada (24)

2024

  1. Exposure to different occupational chemicals and clinical phenotype of a cohort of patients with systemic sclerosis

    Autoimmunity Reviews

2022

  1. Cardiovascular risk factors during cancer treatment. Prevalence and prognostic relevance: insights from the CARDIOTOX registry

    European journal of preventive cardiology, Vol. 29, Núm. 6, pp. 859-868

  2. Heart failure and in-hospital mortality in elderly patients after elective noncardiac surgery in Spain

    Medicina Clinica, Vol. 159, Núm. 7, pp. 307-312

2021

  1. Heart failure is a poor prognosis risk factor in patients undergoing cholecystectomy: Results from a spanish data-based analysis

    Journal of Clinical Medicine, Vol. 10, Núm. 8

  2. Impact of heart failure on in-hospital outcomes after surgical femoral neck fracture treatment

    Journal of Clinical Medicine, Vol. 10, Núm. 5, pp. 1-10

2020

  1. Classification, prevalence, and outcomes of anticancer therapy-induced cardiotoxicity: the CARDIOTOX registry

    European heart journal, Vol. 41, Núm. 18, pp. 1720-1729

  2. Comparison of the Birmingham Vasculitis Activity Score and the Five-Factor Score to Assess Survival in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis: A Study of 550 Patients From Spain (REVAS Registry)

    Arthritis Care and Research, Vol. 72, Núm. 7, pp. 1001-1010

2019

  1. Implicación del tratamiento de la diabetes gestacional en el aumento de peso materno y bajo peso neonatal: gran estudio de cohorte retrospectivo

    Nutricion hospitalaria, Vol. 36, Núm. 6, pp. 1261-1266

2017

  1. Características clínicas al diagnóstico de una cohorte prospectiva de pacientes con lupus eritematoso sistémico atendidos en servicios de Medicina Interna españoles: estudio RELES

    Revista Clinica Espanola, Vol. 217, Núm. 1, pp. 7-14

  2. Clinical characteristics and outcome of Spanish patients with ANCA-associated vasculitides Impact of the vasculitis type, ANCA specificity, and treatment on mortality and morbidity

    Medicine (United States), Vol. 96, Núm. 8

  3. RECALMIN II. Ocho años de hospitalización en las Unidades de Medicina Interna (2007-2014). ¿Qué ha cambiado?

    Revista Clinica Espanola, Vol. 217, Núm. 8, pp. 446-453

  4. RECALMIN: The association between management of Spanish National Health Service Internal Medical Units and health outcomes

    International Journal for Quality in Health Care, Vol. 29, Núm. 4, pp. 507-511

2016

  1. First month prednisone dose predicts prednisone burden during the following 11 months: An observational study from the RELES cohort

    Lupus Science and Medicine, Vol. 3, Núm. 1

  2. Patterns of drug therapy in newly diagnosed Spanish patients with systemic lupus erythematosus

    Clinical and Experimental Rheumatology, Vol. 34, Núm. 3, pp. 466-472

  3. Systemic activity and mortality in primary Sjögren syndrome: Predicting survival using the EULAR-SS Disease Activity Index (ESSDAI) in 1045 patients

    Annals of the Rheumatic Diseases, Vol. 75, Núm. 2, pp. 348-355

2015

  1. Nationwide study on the use of intravascular catheters in internal medicine departments

    Journal of Hospital Infection, Vol. 90, Núm. 2, pp. 135-141

  2. Two-week, high-dose proton pump inhibitor, moxifloxacin triple Helicobacter pylori therapy after failure of standard triple or non-bismuth quadruple treatments

    Digestive and Liver Disease, Vol. 47, Núm. 2, pp. 108-113

2014

  1. Diagnosis and allergen immunotherapy treatment of polysensitised patients with respiratory allergy in Spain: An Allergists' Consensus

    Clinical and Translational Allergy, Vol. 4, Núm. 1

  2. Recomendaciones para una prescripción segura de antiinflamatorios no esteroideos: Documento de consenso elaborado por expertos nominados por 3 sociedades científicas (SER-SEC-AEG)

    Gastroenterologia y Hepatologia, Vol. 37, Núm. 3, pp. 107-127

  3. Recomendaciones para una prescripción segura de antiinflamatorios no esteroideos: Documento de consenso elaborado por expertos nominados por 3 sociedades científicas (SER-SEC-AEG)

    Reumatologia Clinica, Vol. 10, Núm. 2, pp. 68-84